Skip to main content
Advertisement
Advertisement

CRL

CRL logo

Charles River Laboratories International, Inc.

292.84
USD
Sponsored
-1.60
-0.54%
Sep 25, 15:59 UTC -4
Closed
exchange

After-Market

292.50

-0.34
-0.12%

CRL Earnings Reports

Positive Surprise Ratio

CRL beat 42 of 42 last estimates.

100%

Next Report

Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$966.64M
/
$2.98
Implied change from Q2 26 (Revenue/ EPS)
-3.73%
/
-1.32%
Implied change from Q3 25 (Revenue/ EPS)
-3.80%
/
+22.63%

Charles River Laboratories International, Inc. earnings per share and revenue

On Aug 05, 2026, CRL reported earnings of 3.02 USD per share (EPS) for Q2 26, beating the estimate of 2.76 USD, resulting in a 9.23% surprise. Revenue reached 1.00 billion, compared to an expected 985.44 million, with a 1.89% difference. The market reacted with a +11.36% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 13 analysts forecast an EPS of 2.98 USD, with revenue projected to reach 966.64 million USD, implying an decrease of -1.32% EPS, and decrease of -3.73% in Revenue from the last quarter.
FAQ
For Q2 2026, Charles River Laboratories International, Inc. reported EPS of $3.02, beating estimates by 9.23%, and revenue of $1.00B, 1.89% above expectations.
The stock price moved up 11.36%, changed from $234.12 before the earnings release to $260.72 the day after.
The next earning report is scheduled for Nov 03, 2026.
Based on 13 analysts, Charles River Laboratories International, Inc. is expected to report EPS of $2.98 and revenue of $966.64M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement